Evidence map›Paper›PMID 21044361›Full record

ArticleBMC bioinformatics2010

Multi-dimensional discovery of biomarker and phenotype complexes.

Philip R O Payne, Kun Huang, Kristin Keen-Circle, Abhisek Kundu, Jie Zhang, Tara B Borlawsky

Abstract read
In one paragraph

Article in BMC bioinformatics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The TOKEn project: knowledge synthesis for in silico science.Journal of the American Medical Informatics Association : JAMIA · 2011
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Philip R O PayneDepartment of Biomedical Informatics, The Ohio State University, 3190 Graves Hall, 333 West 10th Avenue, 43210, Columbus, Ohio, USA. philip.payne@osumc.edu
Kun Huang
Kristin Keen-Circle
Abhisek Kundu
Jie Zhang
Tara B Borlawsky

Funding

Tissue CoreP01CA081534 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 2000 to 2016
$59.5M
Re-engineering the CRC Integrated Information Management SystemR01CA134232 · NCI · OHIO STATE UNIVERSITY · PI PAYNE, PHILIP R.O. · 2008 to 2011
$1.3M
NCI NIH HHS 1R01CA134232-01NCI NIH HHS 2 P01CA081534-07A1
6 · The paper itself

Abstract

backgroundGiven the rapid growth of translational research and personalized healthcare paradigms, the ability to relate and reason upon networks of bio-molecular and phenotypic variables at various levels of granularity in order to diagnose, stage and plan treatments for disease states is highly desirable. Numerous techniques exist that can be used to develop networks of co-expressed or otherwise related genes and clinical features. Such techniques can also be used to create formalized knowledge collections based upon the information incumbent to ontologies and domain literature. However, reports of integrative approaches that bridge such networks to create systems-level models of disease or wellness are notably lacking in the contemporary literature.

resultsIn response to the preceding gap in knowledge and practice, we report upon a prototypical series of experiments that utilize multi-modal approaches to network induction. These experiments are intended to elicit meaningful and significant biomarker-phenotype complexes spanning multiple levels of granularity. This work has been performed in the experimental context of a large-scale clinical and basic science data repository maintained by the National Cancer Institute (NCI) funded Chronic Lymphocytic Leukemia Research Consortium.

conclusionsOur results indicate that it is computationally tractable to link orthogonal networks of genes, clinical features, and conceptual knowledge to create multi-dimensional models of interrelated biomarkers and phenotypes. Further, our results indicate that such systems-level models contain interrelated bio-molecular and clinical markers capable of supporting hypothesis discovery and testing. Based on such findings, we propose a conceptual model intended to inform the cross-linkage of the results of such methods. This model has as its aim the identification of novel and knowledge-anchored biomarker-phenotype complexes.

Indexed as

PhenotypeBiomarkersComputational BiologyGene Regulatory NetworksNational Cancer Institute (U.S.)Translational Research, BiomedicalUnited StatesBiomarkers

Identifiers

PMID21044361
PMCPMC2967744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.